Lars Welzing

1.1k total citations
24 papers, 748 citations indexed

About

Lars Welzing is a scholar working on Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health and Anesthesiology and Pain Medicine. According to data from OpenAlex, Lars Welzing has authored 24 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 13 papers in Pediatrics, Perinatology and Child Health and 8 papers in Anesthesiology and Pain Medicine. Recurrent topics in Lars Welzing's work include Neonatal Respiratory Health Research (13 papers), Anesthesia and Sedative Agents (7 papers) and Neuroscience of respiration and sleep (6 papers). Lars Welzing is often cited by papers focused on Neonatal Respiratory Health Research (13 papers), Anesthesia and Sedative Agents (7 papers) and Neuroscience of respiration and sleep (6 papers). Lars Welzing collaborates with scholars based in Germany, United States and Tunisia. Lars Welzing's co-authors include Bernhard Roth, Angela Kribs, Frank Eifinger, H. Stützer, Katrin Mehler, Christoph Huenseler, André Oberthuer, Bradley J. Roth, Claudia Roll and Wolfgang Göpel and has published in prestigious journals such as Anesthesiology, Intensive Care Medicine and Drugs.

In The Last Decade

Lars Welzing

24 papers receiving 729 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Welzing Germany 13 478 323 241 221 180 24 748
Outi Peltoniemi Finland 15 597 1.2× 325 1.0× 122 0.5× 39 0.2× 250 1.4× 29 730
Marja‐Leena Pokela Finland 11 250 0.5× 338 1.0× 66 0.3× 108 0.5× 87 0.5× 14 539
Massimo Micaglio Italy 15 407 0.9× 111 0.3× 134 0.6× 269 1.2× 183 1.0× 34 592
Ermelinda Pelausa Canada 6 205 0.4× 531 1.6× 24 0.1× 109 0.5× 51 0.3× 8 609
Cynthia H. Cole United States 16 999 2.1× 412 1.3× 173 0.7× 22 0.1× 477 2.6× 31 1.2k
Amber V. Hoover United States 8 282 0.6× 126 0.4× 98 0.4× 45 0.2× 95 0.5× 8 593
Margarita Bidegain United States 14 202 0.4× 275 0.9× 30 0.1× 32 0.1× 58 0.3× 26 447
David Sommerfield Australia 15 120 0.3× 130 0.4× 15 0.1× 236 1.1× 146 0.8× 56 499
Anoop Ramgolam Australia 12 185 0.4× 131 0.4× 16 0.1× 267 1.2× 109 0.6× 18 459
Henriëtte A. van Zanten Netherlands 14 404 0.8× 163 0.5× 166 0.7× 48 0.2× 111 0.6× 25 475

Countries citing papers authored by Lars Welzing

Since Specialization
Citations

This map shows the geographic impact of Lars Welzing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Welzing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Welzing more than expected).

Fields of papers citing papers by Lars Welzing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Welzing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Welzing. The network helps show where Lars Welzing may publish in the future.

Co-authorship network of co-authors of Lars Welzing

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Welzing. A scholar is included among the top collaborators of Lars Welzing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Welzing. Lars Welzing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Göpel, Wolfgang, Angela Kribs, Claudia Roll, et al.. (2022). Multi‐centre randomised trial of invasive and less invasive surfactant delivery methods showed similar spirometry results at 5–9 years of age. Acta Paediatrica. 111(11). 2108–2114. 6 indexed citations
2.
Mehler, Katrin, Claudia Roll, Wolfgang Göpel, et al.. (2020). Developmental outcome of extremely preterm infants is improved after less invasive surfactant application: Developmental outcome after LISA. Acta Paediatrica. 110(3). 818–825. 27 indexed citations
3.
Müeller, Andreas, Lars Welzing, Heiko Reutter, et al.. (2015). Antioxidative status and oxidative stress in the fetal circulation at birth: the effects of time of delivery and presence of labor. Early Human Development. 91(2). 119–124. 12 indexed citations
4.
Kribs, Angela, Claudia Roll, Wolfgang Göpel, et al.. (2015). Nonintubated Surfactant Application vs Conventional Therapy in Extremely Preterm Infants. JAMA Pediatrics. 169(8). 723–723. 249 indexed citations
7.
Lindner, Ulrike, André Oberthuer, Lars Welzing, et al.. (2011). Angiotensin II Receptor Blocker Induced Fetopathy: 7 Cases. Klinische Pädiatrie. 223(1). 10–14. 21 indexed citations
8.
Bağcı, Soyhan, J. Reinsberg, Berndt Zur, et al.. (2011). Melatonin concentration in umbilical cord blood depends on mode of delivery. Early Human Development. 88(6). 369–373. 10 indexed citations
9.
Welzing, Lars, et al.. (2011). Remifentanil Degradation in Umbilical Cord Blood of Preterm Infants. Anesthesiology. 114(3). 570–577. 35 indexed citations
10.
Welzing, Lars, Angela Kribs, Frank Eifinger, et al.. (2010). Propofol as an induction agent for endotracheal intubation can cause significant arterial hypotension in preterm neonates. Pediatric Anesthesia. 20(7). 605–611. 70 indexed citations
11.
Welzing, Lars, Anne Vierzig, Frank Eifinger, et al.. (2010). Remifentanil and propofol for weaning of mechanically ventilated pediatric intensive care patients. European Journal of Pediatrics. 170(4). 477–481. 6 indexed citations
12.
Welzing, Lars, Soyhan Bağcı, Alina Abramian, et al.. (2010). CPAP combined with inhaled nitric oxide for treatment of lung hypoplasia and persistent foetal circulation due to prolonged PPROM. Early Human Development. 87(1). 17–20. 10 indexed citations
13.
Schmidt, Beate, et al.. (2009). Comparison of Sufentanil versus Fentanyl in Ventilated Term Neonates. Klinische Pädiatrie. 222(2). 62–66. 21 indexed citations
14.
Welzing, Lars, Angela Kribs, Christoph Huenseler, et al.. (2009). Remifentanil for INSURE in preterm infants: a pilot study for evaluation of efficacy and safety aspects. Acta Paediatrica. 98(9). 1416–20. 39 indexed citations
16.
Lüers, Jan-Christoffer, Lars Welzing, Bernhard Roth, & Michael Streppel. (2008). Traumatic luxation of the nose in a newborn: case report and review of the literature. European Archives of Oto-Rhino-Laryngology. 266(9). 1489–1493. 6 indexed citations
17.
Kribs, Angela, Anne Vierzig, Christoph Hünseler, et al.. (2008). Early surfactant in spontaneously breathing with nCPAP in ELBW infants – a single centre four year experience. Acta Paediatrica. 97(3). 293–298. 67 indexed citations
18.
Welzing, Lars, et al.. (2008). Rapid development of life-threatening complete atrioventricular block in Kearns-Sayre syndrome. European Journal of Pediatrics. 168(6). 757–759. 19 indexed citations
19.
Welzing, Lars, et al.. (2007). Consequences of Directive 2001/20/EC for investigator-initiated trials in the paediatric population—a field report. European Journal of Pediatrics. 166(11). 1169–1176. 11 indexed citations
20.
Welzing, Lars & Bernhard Roth. (2006). Experience with Remifentanil in Neonates and Infants. Drugs. 66(10). 1339–1350. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026